Fundraising Fox
Paul Grint
Executive Chairman & Interim CEO at Codagenix
Find your path to Paul
Sign up to see every warm intro you have to Paul
- Paths you didn't know you had: your email and LinkedIn already hold routes to Paul. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Grint has led several biopharmaceutical companies, serving as CEO of AmpliPhi Biosciences and as President and CEO of Regulus Therapeutics. He also chairs CRISPR QC, is an entrepreneur in residence at the University of California San Diego, and has served on the boards of Persephone Biosciences, Inhibikase Therapeutics, and Synedgen.
Frequently asked questions
- Who is Paul Grint?
- Grint has led several biopharmaceutical companies, serving as CEO of AmpliPhi Biosciences and as President and CEO of Regulus Therapeutics. He also chairs CRISPR QC, is an entrepreneur in residence at the University of California San Diego, and has served on the boards of Persephone Biosciences, Inhibikase Therapeutics, and Synedgen.
About this profile. Compiled from public sources — the organisations' own websites and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights